mr. samson has served as a member of our board of directors since august 2018. he founded and has served as the chief executive officer of samson medical technologies, l.l.c., a company specializing in injectable drug delivery systems and programs for hospital and alternate site pharmacists, since 1998.mr. samson was also chief executive officer and chairman of the board of directors of qualitest pharmaceuticals inc., a pharmaceutical company, from 2007 until its purchase by endo pharmaceuticals at the end of 2010. prior to qualitest pharmaceuticals, he served as president, chief executive officer and a member of the board of directors of sicor, inc., a pharmaceutical company previously listed on the nasdaq, from 2001 until it was acquired by teva pharmaceutical industries, ltd., a pharmaceutical company, in 2004, after which he served as the group vice president of worldwide injectables of teva until 2007.prior to that, mr. samson was the founder, president and chief executive officer of marsam pharmaceuticals inc. (nasdaq: msam), a publicly held pharmaceutical company until its acquisition in 1995, from 1985 to 1998, and a founder, president and chief executive officer of elkins-sinn, inc. (now west-ward, a division of hikma pharmaceuticals), from 1967 through 1985.mr. samson currently serves on the boards of directors of public company antares pharma, inc. (nasdaq: atrs), as well as privately held companies flynn pharma ltd. and nanopass technologies ltd. he also serves as chairman of the board of directors of privately held company heritage pharmaceuticals, inc. mr. samson previously served on the boards of directors of circassia pharmaceuticals plc, a specialty biopharmaceutical company public in the united kingdom, as well as privately held companies jhp pharmaceuticals, llc (prior to its acquisition by par pharmaceutical companies inc.), emcure pharmaceuticals, ltd. and baxa corporation (prior to its acquisition by baxter international).mr. samson is also chairman of the board of trustees of the university of the sciences in philadelphia and a trustee of two non-profit organizations, virtua health system and the franklin institute. mr. samson holds five u.s. patents pertaining to pharmaceutical manufacturing. he holds a b.s. in chemistry from temple university.